Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

82.74 +2.90 (+3.63%)
Official Closing Price Updated: 7:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,377,588
Open 80.17
Bid (Size) 82.55 (1)
Ask (Size) 82.70 (1)
Prev. Close 79.84
Today's Range 78.06 - 83.28
52wk Range 75.93 - 134.63
Shares Outstanding 2,531,374,696
Dividend Yield 3.92%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These S&P500 stocks are moving in today's session
Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
Merck Stays Confident On M&A Despite Market Uncertainty: Analyst
Merck projects $200 million in tariff costs, boosts U.S. manufacturing plans, and continues M&A efforts amid external pressures and shifting market dynamics. 
Via Benzinga
Topics World Trade
Exposures Tariff

Performance

YTD
-16.6%
-16.6%
1 Month
-5.8%
-5.8%
3 Month
-14.4%
-14.4%
6 Month
-21.9%
-21.9%
1 Year
-34.9%
-34.9%

More News

Read More
What's Going On With Summit Therapeutics Stock On Friday?
Via Benzinga
Exposures Product Safety
Market Monitor April 25 ( Texas Instruments, Nvidia & Amazon UP, IBM, PepsiCo & Comcast DOWN)
Via Chartmill
Earnings Scheduled For April 24, 2025
Via Benzinga
Merck (MRK) Q1 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings World Trade
Exposures Financial Tariff
Halozyme Sues Merck Over Subcutaneous Keytruda Formulation, Seeks Injunctive Relief
Via Stocktwits
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
Merck's Q1 Earnings Beat Wall Street, Adjusts 2025 Profit Outlook As Tariffs May Result In Incremental Cost Of $200 Million
Via Benzinga
Topics Earnings
Exposures Financial
Merck & Co. Reports Better Than Expected Results For First-Quarter 2025
Via Talk Markets
Topics Stocks / Equities
Durable Goods Orders Jump 9.2% In March, But One Category Tells The Real Story
Via Benzinga
Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday?
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Merck Reports Strong Q1 Earnings But Downgrades Full-Year Guidance: Retail Sentiment Brightens
Via Stocktwits
Topics Government World Trade
Exposures Political Tariff
Merck’s (NYSE:MRK) Q1 Sales Beat Estimates
Via StockStory
Topics Artificial Intelligence Earnings Intellectual Property
Exposures Artificial Intelligence Financial Intellectual Property
Gardasil Sales Decline — Again. Can Dow Jones Stock Merck Take The Hit?
Via Investor's Business Daily
Topics Earnings Government Stocks
Exposures Financial Political US Equities
Merck Announces First-Quarter 2025 Financial Results
From Merck & Co., Inc.
Via Business Wire
Why Is Summit Therapeutics Stock Soaring On Wednesday?
Via Benzinga
Merck Stock Slumps Ahead Of Q1 Earnings: Can Bulls Find Relief In Buying Pressure?
Via Benzinga
BioNTech Surges On Summit's Coattails. But Can They Take On Merck?
Via Investor's Business Daily
Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings
Via StockStory
Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer
Via Benzinga
Gilead Announces Positive Results From Trodelvy-Keytruda Combo Study For Breast Cancer: But Retail’s Unmoved
Via Stocktwits
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Why Merck, Black Hills, And Virtus Investment Partners Are Winners For Passive Income
Via Benzinga
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
Via Benzinga
Topics ETFs
Where Will Eli Lilly Be in 5 Years?
Via The Motley Fool

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 82.74
When was Merck & Co last traded?
The last trade of Merck & Co was at 04/25/25 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 209.45B
How many shares of Merck & Co are outstanding?
Merck & Co has 209B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.